Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KLRS | Kalaris Therapeutics, Inc. | Officer Title: President, Chief Financial Officer and Chief Executive Officer, Director, 10%+ Owner | $7.8M | -$30.2K | -0.39% | Feb 21, 2025 |
VRNA | Verona Pharma plc | Director | Apr 29, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|